top of page
The latest on cardiometabolic disease and Covid-19
Search
Experimental treatments and controversies, a review
Quality of evidence: C Controversial treatments: an updated understanding of the Coronavirus Disease 2019 Authors: Zhang C et al Journal:...
Abderrahim Benmoussa, phD
Apr 7, 20202 min read
31 views
0 comments
Heparin and mortality in patients with coagulopathy, a retrospective cohort study
Quality of evidence: B- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with...
Abderrahim Benmoussa, phD
Apr 7, 20201 min read
4 views
0 comments
Early use of short term corticosteroids therapy, an open-label non-randomized monocentric trial
Quality of evidence: C- Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
4 views
0 comments
Anti-inflammatory drugs and severe cases, a review, and expert position from China
Quality of evidence: C+ The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19):...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
4 views
0 comments
Management of critically ill adults, a guideline summary for practioners
Quality of evidence: B- Management of Critically Ill Adults With COVID-19 Authors: Poston JT et al. Journal: JAMA Objectives: Centralize...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
7 views
0 comments
Withdrawing renin-angiotensin inhibitors in COVID-19? A short review of the literature
Quality of evidence: D SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Authors:...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
5 views
0 comments
On Ibuprofen-associated risk during COVID-19, a news story
Quality of evidence: C- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists Authors: Michael Day...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
4 views
0 comments
Liver injury and severe coronavirus infections, a summary of the evidence
Quality of evidence: C+ Liver injury during highly pathogenic human coronavirus infections Authors: Xu L et al. Journal: Liver...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
7 views
0 comments
Treatment of COVID-19-induced myocarditis in a young adult, a case report
Quality of evidence: D Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin Authors: Hu H et al Journal: ...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
5 views
0 comments
Are Hypertension and Diabetes risk factors for COVID-19? A short summary of the evidence
Quality of evidence: C - Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Authors: Fang et...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
2 views
0 comments
QT and Hydroxychloroquine/Azithromycin, a retrospective cohort study
Strength of evidence: C+ The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin Authors:...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
29 views
0 comments
Treatment and prognosis, a retrospective cohort study
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-
Abderrahim Benmoussa, phD
Apr 4, 20201 min read
35 views
0 comments
bottom of page